In contrast, our study failed to demonstrate significant elevations of CSF NFL in ANI and MND individuals when compared with neurocognitively normal HIV-infected individuals, although we do not have a seronegative control group to determine whether CSF NFL is elevated in our seropositive neurocognitively normal control group. This evidence concerns the gene NEFL and asymptomatic neurocognitive impairment.